PsyBio Therapeutics Corp.
OOTC:PSYBFCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
Company News
PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale
PsyBio Therapeutics successfully completes first pre-IND meeting with the FDA
PsyBio Therapeutics presents 16 scientific abstracts highlighting its research and development efforts at two scientific conferences
PsyBio Therapeutics shares updates on intellectual property and clinical development milestones
PsyBio Therapeutics is developing psychoactive compounds which could be a mental health game changer
PsyBio Therapeutics announces expansion of its intellectual property portfolio by filing six additional patent applications
PsyBio Therapeutics to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th
PsyBio Therapeutics successfully demonstrates commercial-scale manufacturing feasibility
PsyBio Therapeutics submits its first pre-IND application meeting request to FDA
PsyBio Therapeutics inducted into AdvisorShares Psychedelics ETF